Cargando…
The Value of Herbarium Collections to the Discovery of Novel Treatments for Alzheimer’s Disease, a Case Made With the Genus Eriodictyon
Plants, in particular those with a history in traditional medicine, hold enormous potential as sources of new therapies for dementias such as Alzheimer’s disease (AD). The largest collections of plants can be found in herbaria all over the world, but the value of these collections to AD drug discove...
Autores principales: | Maher, Pamela, Fischer, Wolfgang, Liang, Zhibin, Soriano-Castell, David, Pinto, Antonio F. M., Rebman, Jon, Currais, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076189/ https://www.ncbi.nlm.nih.gov/pubmed/32210808 http://dx.doi.org/10.3389/fphar.2020.00208 |
Ejemplares similares
-
Old age-associated phenotypic screening for Alzheimer's disease drug candidates identifies sterubin as a potent neuroprotective compound from Yerba santa
por: Fischer, Wolfgang, et al.
Publicado: (2018) -
The neuronal cell cycle as a mechanism of pathogenesis in
Alzheimer's disease
por: Currais, Antonio, et al.
Publicado: (2009) -
Geroprotective effects of Alzheimer’s disease drug candidates
por: Kepchia, Devin, et al.
Publicado: (2021) -
CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease
por: Ates, Gamze, et al.
Publicado: (2020) -
X-Ray Fluorescence Ionomics of Herbarium Collections
por: van der Ent, Antony, et al.
Publicado: (2019)